Literature DB >> 9236586

Sickle cell disease and tonsillectomy. Preoperative management and postoperative complications.

D J Halvorson1, V McKie, K McKie, P E Ashmore, E S Porubsky.   

Abstract

BACKGROUND: Patients with sickle cell disease are recognized as having a relatively higher risk for postoperative complications, including fever, atelectasis, pneumonia, or sickle cell vas-occlusion.
OBJECTIVE: To present a protocol for preoperative management of patients with sickle cell disease undergoing tonsillectomy, including the use of transfusions and intravenous hydration.
DESIGN: Retrospective chart review.
SETTING: Academic, tertiary care referral medical center. PATIENTS: Seventy-five patients with sickle cell disease who underwent tonsillectomy with or without adenoidectomy were included for review. Preoperative management was documented, and risk factors were assessed. Intraoperative management was reviewed, and postoperative complications were identified and compared with preoperative data and management.
RESULTS: Preoperative management consisted of transfusions to a hemoglobin S ratio (hemoglobin S-total hemoglobin) less than 40% or a hemoglobin level greater than 100 g/L. Aggressive intravenous hydration of 1.5 times the maintenance fluid was given 24 hours before surgery. Increased complications were associated with a preoperative hemoglobin S ratio greater than 40% (P < .05) and an age younger than 4 years (P < .05). Operative time, technique, and blood loss were not statistically significant risk factors. The average length of hospitalization was 4.8 days.
CONCLUSIONS: Children with sickle cell disease presenting for elective tonsillectomy should be given a transfusion to a hemoglobin S ratio less than 40% in an attempt to reduce postoperative complications. Additional factors, such as age and presence of obstructive sleep apnea, only increase the potential risks.

Entities:  

Mesh:

Year:  1997        PMID: 9236586     DOI: 10.1001/archotol.1997.01900070033005

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  Tonsillectomy and adenoidectomy for obstructive sleep apnea in sickle cell anemia.

Authors:  Raj Warrier; A Chauhan; U Athale
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

Review 2.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

3.  A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy.

Authors:  D R Leff; T Kaura; T Agarwal; S C Davies; J Howard; A C Chang
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

4.  Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy.

Authors:  Amr Mostafa Aziz; Abdul-Wahed N Meshikhes
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172

Review 5.  Adenotonsillectomy in high risk patients: Hematologic abnormalities and COVID-19 considerations.

Authors:  Ryan Ruiz; Kavita Dedhia
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2021-05-29

Review 6.  Perioperative Management of Sickle Cell Disease.

Authors:  Kwame Ofori Adjepong; Folashade Otegbeye; Yaw Amoateng Adjepong
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.